Neural Basis of Risk Aversion

Researchers identify and manipulate a signal in the brains of rats that controls risky behavior.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, PEMELETHumans and many other animals are generally risk-averse, meaning they will usually choose stable, certain rewards over risky ones, even if the average payoff from both options is the same. Now, researchers at Stanford University have identified—and manipulated—a specific signal in the brains of rats that determines risky behavior just before the animals make a decision. The findings were published yesterday (March 23) in Nature.

“It turns out you can explain a large part of whether rats were risky or not by this particular signal at this particular time,” study coauthor Karl Deisseroth of Stanford told The New York Times. “We saw it happen, and then we were able to provide that signal, and then see that we could drive the behavior causally.”

Previous research had suggested that an area of the forebrain called the nucleus accumbens plays an important role in decision-making. Part of the reward system of the brain, this region contains neurons with receptors for dopamine, a chemical producing feelings of pleasure.

To investigate the role of these neurons in risky decision-making, the researchers implanted an optical fiber into the nucleus accumbens of 17 rats. They then ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies